secwatch / observer
8-K filed April 9, 2024, 7:59 PM ET ticker ESAB CIK 0001877322
debt confidence high sentiment neutral materiality 0.75

ESAB Corp (ESAB): debt financing — ESAB issues $700M of 6.25% senior notes due 2029 to repay Term Loan A-3

ESAB Corp

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

ESAB Corp incurred senior notes of $700 million with U.S. Bank Trust Company, National Association at 6.25% maturing April 15, 2029.

Instrument
senior notes
Principal
$700 million
Counterparty
U.S. Bank Trust Company, National Association
Rate
6.25%
Maturity
April 15, 2029
Event
incurrence
Exact text from the filing
On April 9, 2024, ESAB Corporation, a Delaware corporation (the “Company”), issued $700 million in aggregate principal amount of 6.25% senior notes due 2029 (the “Notes”).
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

ESAB Corp entered into Indenture with U.S. Bank Trust Company, National Association valued at $700 million (effective 2024-04-09).

Action
entry
Agreement
notes offering
Counterparty
U.S. Bank Trust Company, National Association
Value
$700 million
Effective
2024-04-09
Exact text from the filing
On April 9, 2024, ESAB Corporation, a Delaware corporation (the “Company”), issued $700 million in aggregate principal amount of 6.25% senior notes due 2029 (the “Notes”). The Notes were issued pursuant to an indenture, dated as of April 9, 2024 (the “Indenture”), by and among the Company, the Guarantors (as defined below) and U.S. Bank Trust Company, National Association (the “Trustee”).
View on SEC.gov

299 debt financings filed in the last 30 days. Browse all debt financings →

ESAB Corp filing history →

Source: SEC EDGAR
accession 0001628280-24-015484
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.